With a market cap of $62.4 billion, Regeneron Pharmaceuticals, Inc. (REGN) discovers, invents, develops, manufactures, and ...

Regeneron's oncology platform is poised to be a significant growth driver in the next decade. Read why REGN stock remains a ...

The stock's fall snapped a two-day winning streak.

Sanofi reports amlitelimab improved lung function in asthma, with new phase 3 trials planned across its respiratory pipeline.

Major indices headed south on Tuesday as traders digested a fresh batch of Q1 earnings from more of the nation's biggest ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Fortinet Inc. $99.20 2.35 2.43% ...

S&P/TSX Composite Index 23,587.80 572.93 2.49% ...

Real time quote data is not available at this time.

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

Real time quote data is not available at this time.